Haijen-Bongers, E. C. H. M.
Hurks, P. P. M.
Schepers, J.
Vizeli, P.
Santos de Jesus, J.
Mueller, L.
Schmid, Y.
Liechti, M. E.
Kuypers, K. P. C.
Funding for this research was provided by:
Definium Therapeutics, Inc.
Article History
Received: 18 February 2026
Accepted: 6 June 2026
First Online: 20 June 2026
Declarations
:
: All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments. This study was approved by the Medical Ethics Committee of the Academic Hospital of Maastricht and Maastricht University (NL73910.068.20) and the Ethics Committee of Northwestern and Central Switzerland (BASEC2020-01296).
: Informed consent was obtained from all individual participants included in the study.
: Matthias E. Liechti reported consulting fees and grants from Definium Therapeutics US, Inc. and Lykos Therapeutics outside the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.